SIGNAL TERMINATION – INOVIO PHARMACEUTICALS LONG – CANCEL
Today, the analysis of the rise in the price of CFDs of Inovio Pharmaceuticals shares is canceled. The analysis was preparing for a possible sharp upward break due to the progress of vaccine development on Covid-19. Given the latest data, it appears that this company is not yet at the finish line, so the signal is being canceled.
ORIGINAL TEXT: Inovio Pharmaceuticals Long. Inovio Pharmaceuticals is one of many pharmaceutical companies running a drug race on Covid-19. We don’t know if he wins, but one thing is clear. Capital Analysis analysts believe that if the market breaks the resistance line around the $ 19 exchange rate, the market will get out of the “flag” formation, followed by the activation of the expected purchase traces of orders by the funds. And that needs to be used.
Graph source: WebTrader